Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0.373. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.373
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P01 CA234212
NCI NIH HHS
Grant: R01 CA249811
NCI NIH HHS
Grant: P30 CA047904
National Institutes of Health
Grant: 5P01CA234212-02
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
National Institutes of Health
Grant: 5R01CA249811-05
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
National Institutes of Health
Grant: 3P30CA047904-07S1
CANCER CENTER SUPPORT GRANT
FWCI
1.67
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals